Modern Diagnostic & Research Centre shareholding pattern

MDRC

57

0.00 (0.00%)
Last updated on 3 Jun, 2026 | 09:09 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Modern Diagnostic & Research Centre Shareholding Pattern

  • 2016-17
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

72.85%

Mutual Fund

0%

Insurance

0.12%

Foreign Institutional Investors

0.03%

Domestic Institutional Investors

15.36%

Retail

11.64%

Others

0%

Total Promoters
JAN '26
72.85%
MAR '26
72.85%

Summary

Modern Diagnostic & Research Centre share holding pattern reports the following shareholding: Modern Diagnostic & Research Centre Total Promoters is at 72.85%, Mutual Fund at 0.00%, Insurance at 0.12%, Foreign Institutional Investors at 0.03%, Domestic Institutional Investors at 15.36%, and Retail at 11.64%. This breakdown provides a quick snapshot of ownership distribution for Modern Diagnostic & Research Centre share holding pattern in 2026-27.

Modern Diagnostic & Research Centre FAQs

As of 06-2026, the promoter shareholding in Modern Diagnostic & Research Centre stands at 72.85% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Modern Diagnostic & Research Centre is 0.03% and 15.36% respectively.

The retail shareholding of the Modern Diagnostic & Research Centre is 11.64%.

Changes in shareholding patterns of Modern Diagnostic & Research Centre can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Modern Diagnostic & Research Centre are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost